Erythropoietin-dependent Inhibition of Apoptosis Is Supported by Carboxyl-truncated Receptor Forms and Blocked by Dominant-negative Forms of Jak2
Open Access
- 1 June 1995
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 270 (24), 14500-14504
- https://doi.org/10.1074/jbc.270.24.14500
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Dominant Negative Effects of a Carboxy-Truncated Jak2 Mutant on Epo-Induced Proliferation and Jak2 ActivationBiochemical and Biophysical Research Communications, 1994
- Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cellsNature, 1994
- Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2Nature, 1994
- A Truncated Erythropoietin Receptor and Cell Death: A ReanalysisScience, 1994
- Identification of JAK2 as a growth hormone receptor-associated tyrosine kinaseCell, 1993
- JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietinCell, 1993
- Continuous c-fos expression precedes programmed cell death in vivoNature, 1993
- A death in the life of p53Nature, 1993
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- Erythropoietin Retards DNA Breakdown and Prevents Programmed Death in Erythroid Progenitor CellsScience, 1990